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Gender specific profil of matrix metalloproteinase 3, tissue inhibitors
and inflammatory markers on rheumatic mitral valve stenosis 
Monia Asmi (1), Amira Zaroui (2), Rachid Mechmeche (2), Mouna Ben
Mna (1), Yosra Zayani (1), Wiem Zidi (1), Mohamed Sami Mourali (2),
Sonia Aloui (1), Moncef Feki (1), Neziha Kaabachi (1)
(1) Hôpital la Rabta, Service de biochimie, Tunis, Tunisie – (2) Hôpital la
Rabta, Exploration fonctionnelle et reanimation cardiaque, Tunis, Tunisie
We investigated the profile and the relation of matrix metalloproteinase 3
(MMP-3), tissue inhibitors of matrix metalloproteinases (TIMP-1 and TIMP-2),
and inflammatory markers (high-sensitive C-reactive protein) on rheumatic
mitral valve stenosis (MVS) and restenosis post percutaneaous mitral valve
commissurotomy (PMC) in men and women.
We have enrolled 162 patients with rheumatic mitral stenosis ( 57 male,
45±11.56 y. old )and 88 healthy control subjects (46 male,36±14 y.old.), pre-
vious PVC on 77% patients.
Peripheral blood samples were collected from these subjects to examine the
plasma MMPs -3 and TIMP-1 and TIMP-2 by ELISA and high-sensitive C-
reactive protein (hs-CRP).An echocardiography study was performed to eval-
uate area, anatomy and calcification degree of mitral valve.We observed a
higher plasmatic levels of TIMP-2, hs-CRP and lymphocytes cells count on
MVS patients than control (131.16±74 vs 71.34±47 ng/ml, p=0.02; 2.1 ±1.2
vs 4.6±2.8 mg/l, p=0.002 respectively) and lower level of MMP-3 (9.2±5.3vs
11.2±9.2 ng/ml, p=0.033).In case of restenosis, In men, the MMP-3 level was
higher (16.39±5.7 vs 11.19±4.58 ng/ml, p=0.034), we observed a more severe
MV calcification score. However, in women, we didn't relived a significant
difference on MMP-3 level (7.47±3.6 vs 7.41±3.6 ng/ml ), but a higher level
of TIMP-2 and MMP-3 /TIMP-2 ratio. We observed also a significant higher
levels of inflammatory markers  but a lower calcification score. Positive cor-
relation was found in women between calcification degree and MMP-3 plas-
matic level  (r=0.678, p<0.001), and between hs-CRP and MMP-3 (r=0.345,
p=0.002). In men, only a correlation between MMP-3and calcification degree
were observed (r=0.456, p=0.05).This study suggest an implication of the
MMP-3/TIMP system in ECM remodelling on rheumatic MS and demon-
strates different patterns of association between inflammatory markers and
MMP-3 in men and women, strengthening the hypothesis of gender specific
differences in pathophysiological mechanisms of mitral stenosis evolution and
calcification 
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Relationship between anatomic and hemodynamic progression in aor-
tic stenosis – impact of the degree of AS severity
Virginia Nguyen (1), Claire Cimadevilla (1), Alec Vahanian (1), David
Messika-Zeitoun (2)
(1) Hôpital Bichat-Claude Bernard, Paris, France – (2) Hôpital Bichat-
Claude Bernard, Cardiologie, Paris, France
Background: Aortic stenosis (AS) is mainly caused by progressive cal-
cium deposition within the valve leaflets. Aortic valve calcification (AVC) can
be accurately measured using Multi-Detector-Computed-Tomography
(MDCT) but the relationship between anatomic progression (calcium burden
or AVC) and haemodynamic progression (aortic valve area (AVA)) has not
been specifically evaluated.
Methods: In 146 patients with at least mild AS (AVA < 2 cm²) enrolled
in an ongoing prospective cohort, we performed an echocardiographic evalu-
ation of AS severity and a measurement of AVC using MDCT at study entry
and at 2 years.
Results: At baseline mean AVA was 1.42±0.4 cm² and mean AVC
1082±871 AU. After 2 years of follow-up, mean AVC increase was
167±166 AU/year and mean AVA decrease -0.09±0.08 cm²/year. There was a
significant correlation between hemodynamic and anatomic changes (r=0.26
p<0.001). Among the 146 patients, 46 had a mild AS (AVA>1.5 cm²), 82 a
moderate AS (AVA 1-1.5 cm²), and 18 a severe AS (AVA<1cm²). Progression
in each group was 120±122 AU/year and -0.10±0.09 cm²/year for mild AS,
166±141 AU/year and -0.08±0.07 cm²/year for moderate AS, and
317±265 AU/year and -0.06±0.05 cm²/year for severe AS. However; the asso-
ciation between hemodynamic and anatomic progression was not significantly
different between the 3 groups of AS severity (p=0.37). 
Conclusion: In this prospective cohort of patients with a wide range of AS
severity we show that 1) there was a linear correlation between anatomic and
hemodynamic changes and 2) that this association was similar among the
3 AS grades. Our results suggest that medical strategy aiming at preventing
AVC progression may be useful in all subset of AS patients including those
with severe AS.
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Effect of volume overload elimination on LV reverse remodelling
after mitral valve surgery in organic MR
Thierry Le Tourneau (1), Yan Topilsky (2), Douglas Mahoney (2), Rakesh
Suri (2), Hartzell Schaff (2), Maurice Enriquez-Sarano (2)
(1) Institut du Thorax, Nantes, France – (2) Mayo Clinic, Rochester,
Etats-Unis
Background: The short and long-term effects of volume overload elimina-
tion on left ventricular (LV) volume, function and systemic hemodynamic
after surgery for chronic organic MR have been poorly explored.
Methods: 224 pts (64±13 years, 70% males) with severe organic MR
referred to surgery underwent serial MR and LV measurements at baseline,
early after surgery and at late follow-up (428 [355-688] days). Peripheral vas-
cular function was also evaluated. Four pts with recurrent MR were excluded
from analyses. 
Results: There was a phased response of the LV. Elimination of volume
overload led to an early drop in LV end-diastolic volume (EDV index: 119±25
to 75±14 mL/m², P<0.0001) after surgery while end-systolic volume (ESV)
did not change. LV EF decreased (71±8 to 54±12%, P<0.0001) but forward
stroke volume increased (38±8 to 40±9 mL/m², P=0.02). Early decline in EDV
was related to pre-op MR volume (r=0.88, P<0.0001). In the late phase, LV
ESV index decreased to 28±9 mL/m² (P<0.0001) while EDV index decreased
further and LV EF increased to 60±8% (P<0.0001). Systemic vascular
compliance and resistance improved. Surgery was performed early (Early) in
80 pts and later in 140 pts (Classical). Pre-op LV remodeling was worse in the
Classical group. Despite a significant LV reverse remodeling in both groups,
LV volumes remained higher and LV EF lower in the Classical group
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compared with the Early group at late follow-up and vascular function
remained impaired.
Conclusion: LV reverse remodeling after surgery for organic MR is a
phased process. The initial step is driven essentially by the elimination of
regurgitant volume with a proportional decline in EDV while ESV does not
change and LV EF decreases. Long-term improvement of LV EF depends on
a further decrease in EDV associated with a decrease in ESV. Patients oper-
ated early experience a more complete LV reverse remodelling, and a greater
LV EF and vascular function recovery compared with classical indications.
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Impact of valve surgery in patients with infective endocarditis and
neurological complications
Christine Selton-Suty (1), Claire Federspiel (1), François Delahaye (2),
Bernard Iung (3), Pierre Nazeyrollas (4), Yvette Bernard (5), Erwan
Donal (6), Catherine Sportouch-Dukhan (7), François Alla (1), Bruno
Hoen (5), Xavier Duval (3)
(1) CHU Brabois, Vandoeuvre Les Nancy, France – (2) CHU Lyon, Lyon,
France – (3) Hôpital Bichat-Claude Bernard, Paris, France – (4) CHU
Reims, Reims, France – (5) CHU Besançon, Besançon, France – (6) CHU
Rennes, Rennes, France – (7) CHU Montpellier, Montpellier, France
Neurologic complications (NC) are a major cause of morbidity and mor-
tality in pts with infective endocarditis (IE) and may prevent pts from
receiving valve surgery. 
Methods: Among 399 cases of Li definite left-sided IE collected during a
one-year prospective population-based survey, 100 had at least one symp-
tomatic neurological complication (SNC). NC included transient ischemic
attack, ischemic stroke, cerebral hemorrhage, meningitis, brain abscess and
intracranial mycotic aneurysm. A neuroimaging procedure was performed in
183 of the remaining pts which diagnosed 35 asymptomatic (As) NC and was
considered normal in 148 pts (NoNC). 
Results: Among pts with SNC, 40 episodes occurred after the beginning
of IE antibiotic therapy (21 during the first 48 hours). Mechanical prosthetic
IE (OR 3.4, p=0.007), S.aureus IE (OR 1.8, p=0.03) and mitral IE (OR 2.0,
p=0.008) were predictive of the occurrence of NC. Among the 135 NC pts,
age, renal failure, septic shock and S.aureus as responsible micro-organism
were predictive of in-hospital (33%) and 1-year mortality (38%). Furthermore,
a symptomatic NC was also predictive of 1-year mortality. Rate of surgery
was not different between pts with and without NC (52% vs 57%) but was
significantly higher in AsNC than in SNC (77% vs 43%). In hospital mortality
was higher in pts with NC than in noNC pts (33% vs 17%, p=0.001) and in
SNC than in AsNC (42% vs 9%, p=0.0003). Among the 135 NC pts, 95 had
a surgical indication (71%) which was performed in 70 (mortality 20%) and
not performed in 25 (mortality 68%). 
Conclusion: The presence of NC is associated with a poor prognosis when
it is symptomatic. However, when NC is discovered on systematic neuro-
imaging, it is associated with a very high rate of surgery and a better prognosis
than that of pts with SNC and even without NC, suggesting a protective role
of surgery.
129
Mid-term results of the self–testing of the international normalized
ratio in adults with a mechanical heart valve
Kasra Azarnoush (1), Enrica Dorigo (1), Bruno Pereira (2), Claire Dau-
phin (3), Etienne Geoffroy (1), Nicolas Dauphin (1), Nicolas D'Ostrevy
(1), Benoit Legault (1), Lionel Camilleri (1)
(1) CHU Clermont-Ferrand, Chirurgie cardiovasculaire, Clermont-
Ferrand, France – (2) CHU Clermont-Ferrand, Unité de biostatistiques,
Clermont-Ferrand, France – (3) CHU Clermont-Ferrand, Service de Car-
diologie, Clermont-Ferrand, France
The study protocol on the use of Dabigatran in patients with mechanical
valves was interrupted by the laboratory Boehringer Ingelheim. The vitamin K
antagonists (VKA) remain currently the only molecules used for the preven-
tion of complications related to thromboembolism in this group of patients.
The quality of life of patients with mechanical valve prosthesis mainly
depends on the stability of the INR (international normalized ratio), which is
achieved by an optimal biological monitoring, and guarantees the absence of
unwanted events related to anticoagulation. The objective of this study is to
show that INR self-measurement at home is reliable and feasible and that it is
the key to improve the patients’ medical care.
Methods: All patients in the study concerning the INR self-measurement
(clinicaltrials.gov: NCT00925197) conducted between the years 2004 and
2007 were contacted again to allow the medium term follow-up. In total,
178 patients among the 192 patients who participated to the study answered
the questionnaire. The average patients follow-up was 4.2 years for the self-
measurement group and 4.9 years for the control group.
Results: Among these patients, only 26 (group A) continued to use the
INR self-measurement to monitor their VKA treatment. The main reasons for
the interruption of the use of INR self-measurement mentioned by the patients
are the high cost and the difficulty to get bandages supply. There were signi-
ficantly fewer bleeding complications (p=0.04) and fewer complications
related to VKA (p=0.01) for patients in group A compared to the control
group (group B). 
Conclusion: Despite the lack of the cost covering of the INR monitoring by
self-measurement in adults with a mechanical heart valve, some patients continue
to use this method for their long-term follow-up. These patients present a
significant reduction of the bleeding accidents rate and / or thromboembolism
associated to VKA and a significant improvement of their quality of life.
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Aortic root diameter in patients with spontaneous cervical artery
dissection
Lucie Bobillo (1), Fabien Labombarda (2), Adèle Fournier (2), Julien
Cogez (2), Arnaud Pellissier (2), Eric Saloux (1), Paul Milliez (1)
(1) CHU Côte de Nacre, Cardiologie, Caen, France – (2) CHU Caen,
Cardiologie, Caen, France
Background: Spontaneous cervical artery dissections (SCAD) are a well-
recognized cause of ischemic stroke among young and middle-aged indivi-
duals. The exact pathogenesis of this condition remains unknown. It was pro-
posed that an underlying vasculopathy originating from disturbed
development of extra cellular matrix could exist. Aortic remodelling is usually
seen in such extracellular matrix abnormalities. The aim of the study was to
compare aortic dimensions in patients with SCAD and healthy controls.
Methods: We designed a retrospective single-center case control study.
63 patients with SCAD were identified and compared to a control group
matched to case patients for age (±5 years) and sex. Aortic morphology was
assessed using Trans thoracic echocardiograms (TTE). The diameters of the
aorta were assessed at four levels: aortic annulus, sinuses of Valsalva, sino
tubular junction and proximal ascending aorta.
Results: For men and women, aortic diameters did not differ between the
two groups (aortic annulus: 12.7±1 vs 12.2±1.1 mm/m² , p=0.09 ; sinuses of
Valsalva: 17.8±1 vs 18.6±1.9 mm/m², p=0.7; sino tubular junction: 15.3±0.9
vs 15.9±2.3 mm/m², p=0.67; proximal ascending aorta 17.3±1.6 vs 17.4±2.1,
p=0.87. Unexpectedly, we found 3 patients with bicuspid aortic valve.
Conclusion: In our study, SCAD is not associated to an enlargement of the
aortic root. Bicuspid aortic valve may represent a risk factor for SCAD. 
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Covered stent graft for vessel injury after transfemoral aortic valve
implantation
Christophe Tron (1), Amine Hdiji (1), Bogdan Borz (1), Matthieu Godin
(1), Camille Hauville (1), Eric Durand (2), Alexandre Canville (1), Hélène
Eltchaninoff (1)
(1) CHU Rouen, Cardiologie, Rouen, France – (2) Hôpital Européen
Georges Pompidou (HEGP), Cardiologie, Paris, France
Access site complications remain the most frequent adverse event after
transcatheter aortic valve implantation (TAVI) and are often treated percutane-
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ously with implantation of covered stent graft. However, few data are avail-
able on this topic.
Methods: Between October 2009 and May 2013, 255 Pts underwent TAVI
in our center using the Edwards Sapien XT valve. After gaining vascular
access, a pre-closure technique was performed with a 10-F ProStar XL closure
device. Then, a 16 to 20-F sheath was inserted for 23, 26 or 29 mm valve
implantation. Final ilio-femoral angiography was performed via the contralat-
eral femoral artery after sheath removal and access site closure with the Pro-
Star device. A self-expandable covered stent graft was implanted at vessel
injury site in case of persistent bleeding after prolonged manual compression
or balloon occlusion. 
Results: A covered stent was required in 24 patients (9.4%). Injury was
related to ProStar failure in all. Baseline characteristics and valve size were
similar in Pts requiring or not a covered stent. Pts treated with covered stent
required more contrast (256±104 vs 201±74 ml, p<0.001) and longer fluoros-
copy time (27.9±10.0 vs 19.4±7.1 min, p<0.001). A major vascular complica-
tion occurred in 20 (83.3%) stented Pts and only in 15 (6.5%) non stented Pts
(p<0.0001). ICU and in-hospital stay were longer in stented Pts compared to
non stented Pts (3.2±3.2 vs 2.1±2.5 days, p<0.05, and 13.0±15.1 vs
5.9±5.2 days, p<0.001). However, 30-day mortality was similar between the
2 groups (8.3% vs 5.7%, p=0.59).
Conclusion: Pts undergoing percutaneous TAVI frequently required a cov-
ered stent graft for access site closure failure. Implantation of a covered stent
increases procedural complexity and in-hospital length of stay but has no
effect on 30-day mortality. Technique of covered stent implantation should be
mastered by interventional cardiologists performing TAVI. 
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Comparison of BARC and VRAC criteria for bleeding events assess-
ment after tavi
Nicolas Amabile (1), Sahbi Fradi (1), Said Ghostine (1), Philippe Brenot
(1), Alexandre Azmoun (2), Ramzi Ramadan (2), Remi Nottin (2),
Philippe Deleuze (2), Roxana Mehran (3), Christophe Caussin (1)
(1) Cardiology department, Centre Marie Lannelongue, Le Plessis Robin-
son, France – (2) Cardiac Surgery Department, Centre Marie Lannelon-
gue, Le Plessis Robinson, France – (3) Mount Sinai Hospital, Cardiology
Department, New York, Etats-Unis
Background: TAVI procedures are frequently complicated with hemor-
rhagic events that negatively impact prognosis. Different bleedings classifica-
tions are available for interventional cardiologists, but very few have been
validated for the TAVI procedures.
Aims: To compare the Bleeding Academic Research Consortium (BARC)
and Valve Academic Research Consortium (VARC) classifications for predic-
tion of 1-year mortality in patients undergoing TAVI.
Methods & Results: Between November 2008 and December 2012,
n=260 consecutive patients with symptomatic severe aortic stenosis underwent
TAVI in our institution using transfemoral (83.8%), transapical (12.7%) or
alternative (3.5%) access. Edwards-Sapien© and Medtronic Corevalve© devices
were respectively used in 74% and 26% of the cases. Bleeding events were
assessed with the use of BARC and VARC classifications. The patients were
prospectively followed-up after the procedure and subsequent clinical events
were recorded. A total of n=98 bleeding events were recorded following the
TAVI procedure. These complications were classified as Type 1 (4%), Type
2 (7%), Type 3 (25%) and Type 5 (2%) in the BARC classification and minor
(10%), major (18%) and life-threatening/disabling (11%) according to the
VARC criteria. 
The actuarial global survival was 81.4% at 1 year. The mortality was sig-
nificantly higher in patients with severe bleeding events compared to patients
with minor or no bleeding, irrespective of the classification. The ROC curves
analysis revealed comparable performances of the VARC and BARC scales
for prediction of all-cause mortality. BARC class >2 bleeding was associated
with an increased risk of all-cause mortality (HR=2.4 [1.3-4.2], p=0.004) in
univariable Cox regression analysis. This relationship persisted after adjust-
ment for confounding factors.
Conclusion: Both BARC and VARC classification are appropriate to
assess bleedings severity and provides prognosis information.
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Fetal prognosis after balloon mitral valvotomy during pregnancy
Majed Hassine , Ghassen Chniti, Fatma Ben Amor, Ibtihel Mechri,
Marouen Mahjoub, Zohra Dridi, Fethi Betbout, Habib Gamra
CHU Fattouma Bourguiba, Service de cardiologie A, Monastir, Tunisie
Introduction: Balloon Mitral Valvotomy (BMV) is the treatment of choice
for severe symptomatic mitral stenosis during pregnancy with a better
maternal and fetal prognosis compared to surgery. Several factors may affect
this prognosis
Aim: Study fetal prognosis before and after birth according to the mitral
valve area (MVA) before and after the procedure
Methods and results: 88 pregnant women benefited from BMV for severe
symptomatic mitral between January 1991 and December 2011. The mean
pregnancy term was 27.6+/-5.9 weeks of gestation. All the patients benefited
from a systematic follow up during pregnancy and at delivery. No case of pre-
maturity was noticed. 9 patients underwent a cesarean delivery and the
remaining benefited from a vaginal delivery. No case of fetal distress occurred
with a mean Apgar at birth 8.6+/-1. Preoperative MVA didn't affect birth
weight (p:0.3) neither the term of delivery (p:0.8), while patients with a better
procedural result and MVA > 2 cm2 have given birth to children with higher
weight (3.1 kg+/- 0.4 vs 2.8 kg +/- 0.5kg; p: 0.01).
Conclusion: BMV is safe and effective during pregnancy with a good fetal
prognosis. Post BMV MVA is associated with higher fetal weight. 
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Value of the mean mitral gradient predictive of dyspnea in mitral ste-
nosis in stress echo doppler cardiac at peak effort
Fadila Daimellah (1), Saléha Lehachi (1), Saida Khelil (1), Zakia Bennoui (1),
Djohar Hannoun (2), Youcef Laid (2), Mohand Said Issad (1)
(1) CHU Béni Messous, Cardiologie, Alger, Algérie – (2) Institut National
de Santé Publique Alger, Alger, Algérie
Background: In stress echo Doppler cardiac of mitral stenosis (MS), the
cut point of mean mitral gradient (MMG) at peak of effort proposed by Amer-
ican Guidelines for mitral dilation is 15 mmHg. However this value is ques-
tioned in the literature.
Objective: In stress echo Doppler cardiac, determine the peak effort cutoff
value of MMG prediction of the occurrence of dyspnea justifying mitral dila-
tion in MS.
Methodology: Prospective descriptive study conducted in the Cardiology
Department Hospital  Beni Messous (Algiers Algeria)) between March 2008
and December 2010. Have been included patients with mitral area ≤2cm²,
functional class I,II,III NYHA and systolic pulmonary artery pressure
≤60 mmHg at rest. Dyspnea was sought to stress test on a treadmill: 30 W/3min.
Dyspneic patients are those who have stopped the examination for a load
≤90 Watts due to the occurrence of severe dyspnea. The stress echo Doppler
was performed on table echocardiography: 30 W/3 min. The MMG was mea-
sured at baseline and at the end of each level to the peak of the effort.
Results: 300 patients were included (42.3 years, 81.3% female). At the end
of stress test 182 patients had dyspnea. Areas under the curve of MMG at peak
stress=0.80, 95% confidence interval=0.75-0.85, p<10-3. In predicting dyspnea
justifying mitral dilation, the optimal cutoff value of MMG is 33.5 mmHg:
sensitivity=0.55, specificity=0.96, positive likelihood=13.21, positive predic-
tive value (PPV)=95%, positive predictive error (PPE)=5%, Informative
Expected Capacity (IEC)=109. However, the diagnostic quality of MMG at
maximum effort with the cut point of 15 mmHg proposed by the American
Recommendations is low: sensitivity=0.98, specificity=0.008, positive likeli-
hood=0.98, PPV=60.0%, PPE=40.0%, IEC=0.25.
Conclusion: In this study, the optimal cutoff value of MMG predictive
peak effort dyspnea justifying the mitral dilation is 33.5 mmHg, above the cut
point proposed by the American Guidelines.
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Transvenous Edwards SAPIEN valve implantation in the tricuspid
position
François Godart (1), Alban Baruteau (2), Jean Riou (2), Jérôme Petit (2)
(1) CHRU Lille, Hôpital Cardiologique, Service des Maladies Cardiovas-
culaires Infantiles et Congénitales, Lille, France – (2) Centre Chirurgical
Marie Lannelongue, Le Plessis Robinson, France
We report here 2 patients with Ebstein anomaly in whom percutaneous
tricuspid valve implantation was realised after previous surgical repairs.
Two boys underwent tricuspid valve plasty at the age of 4 and 12 years
respectively. Because of persistent regurgitation, both of them had subse-
quently tricuspid valve replacement by a bioprosthesis (27 mm Mosaic
Medtronic valve in pt 1 at the age of 7 years and 33 mm Carpentier-
Edwards Perimount in pt 2 at the age of 12.5 years) in combination with a
Glenn procedure. Pt 1 had a pacemaker for complete AV block and suffered
of protein losing enteropathy (albumin level of 21 g/L). Pt 2 had a defibril-
lator for VT. During follow-up, both of them had dysfunctional tricuspid
bioprosthesis. Percutaneous implantation of the tricuspid valve performed
from a femoral venous approach at the age of 16 years in pt 1 and 15 years
in pt 2 under rapid pacing by a lead placed in the left ventricle. In pt 1
during valve deployment, the 23 mm Edwards Sapien slipped into the RV
where it became free. Over the extrastiff guidewire, the Sapien valve could
be anchored to the tricuspid annulus by different overlapping stents (CP
stent and a self-expandable stent) and then a second 23 mm Edwards
Sapien was implanted with success. In pt 2, pre-stenting of the tricuspid
annulus (EV3 stent) was realized first, and then a 26 mm Edwards valve
was implanted successfully.
The 4-month follow-up showed clinical amelioration and a mean tricuspid
gradient of 2-4 mm Hg without leak. In pt 1, albumin level increased up to
34 g/L. 
Tricuspid valve-in-valve implantation using the Edwards Sapien valve is
feasible. To secure valve positioning, it may be sometimes advisable to pre-
stent the tricuspid annulus to have an adequate landing zone. To conclude, the
Edwards Sapien valve seems appropriate for implantation in tricuspid position
for selected patients with prior tricuspid valve surgery; however, additional
long-term results including more patients are mandatory.  
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Is aortic stenosis hereditary disease?
Ewa Orlowska-Baranowska (1), Urszula Ablewska (1), Malgorzata
Milkowska (1), Patrycjusz Stoklosa (1), Rafal Baranowski (2), Dariusz
Zakrzewski (2), Tomasz Hryniewiecki (1)
(1) Institute of Cardiology, Valvular Heart Dieseases, Warsaw, Pologne –
(2) Institute of Cardiology, Warsaw, Pologne
Aortic stenosis (AS) is the third most common cause of cardiovascular dis-
ease. Despite such a significant incidence, factors responsible for the defect
and its progression are unknown. Growing evidence suggests that genetic fac-
tors cannot be ruled out.
The aim: to assessed if there is any relation between AS and family his-
tory (FH) of valve disease (VD).
Material and methods: 1237 consecutive pts (599 women, age 64,4 yrs)
before valve replacement (VR) were asked about family history of VD/VR.
977 of them underwent aortic, 189 mitral and 67 more than one valve surgery.
Results: Family history of valve disease was reported in 192 (15%) pts;
92 women and 100 men- ns. It was twice more often in aortic VD – 171(18%)
pts than in pts with mitral VD 17 (9%) (p=0,0001). The incidence of family
history of valve disease in pts with AS was much more higher 159/897
(17,7%) than in rest of the pts with other VD 33/340 (8%).
Conclusions: The incidence of family history of valve disease in pts before
valve surgery is high. Most frequently family history was found in patients
with aortic stenosis and this fact strongly suggests important genetic impact in
this heart valve disease.
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Actual aspects of native valvulopathies in Algiers
Nora Nabila Ali-Tatar Chentir, Lilia Ouabdesselem, Mohand Tayeb Chentir
CHU Mustaph, Cardiologie A1, Alger, Algérie
Objective:  Description of the clinical and echocardiographic profile of
valvulopathies managed in an outpatient unit in Algiers.
Method:  From 2007 to 2011, 675 adult patients, average age 51±12 years,
presenting with a native valvular disease were prospectively assessed by phys-
ical and radiographic examination, transthoracic and transesophageal echo-
cardiography, based on the French Society of Cardiology's recommendations.
Results: The valvulopathies fall into: 
139 mitral stenosis including 44 men and 95 women with an average age
of 45±11 years; 214 mitral regurgitation including 117 men and 97 women
with an average age of 53±14 years; 46 aortic stenosis including 22 men and
24 women with an anverage age of 57±14 years; 42 aortic regurgitation with
an average age of 47±14 including 33 men and 9 women; 234 patients with
multiple cardiac valvulopathies with an average of 50±12 years including
106 men and 128 women.
Conclusion: Rheumatic valvulopathies are still frequent, comparing to
European countries but are getting older than in the seventies. They always
require reinforcing the primary and secondary prevention of rheumatic heart
disease.
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Threshold predictive systolic pulmonary artery pressure of dyspnea in
mitral stenosis in echo doppler of stress 
Saléha Lehachi (1), Fadila Daimellah (1), Saida Khelil (1), Zakia Bennoui (1),
Djohar Hannoun (2), Youcef Laid (2), Imene Hachemaoui (1), Saléha
Lehachi (1), Mohand Said Issad (1)
(1) CHU Béni Messous, Cardiologie, Alger, Algérie – (2) Institut National
de Santé Publique Alger, Alger, Algérie
Background: In mitral stenosis (MS),the threshold of systolic pulmonary
artery pressure (SPAP) in the peak of effort recorded in Doppler cardiac stress
proposed by the Americans Recommendations (AHA / ACC) for mitral dila-
tion is 60 mmHg. However, this value is questioned by many authors.
Objective: Determination in echo Doppler stress, peak effort, value
threshold of SPAP predictive of the occurrence dyspnea justifying percuta-
neous mitral dilation in patients with MS.
Methodology: Descriptive prospective study. From March 2008 to
December 2010. At department of Cardiology Hospital BeniMessous
Algiers. Were included 300 patients, MA≤2 cm² ,functional class I,II,III
NYHA,SPAP ≤60 mmHg at rest Doppler.Gold-standard: dyspnea sought
to stress test. Stress test performed on a treadmill according to the Bruce
protocol (30W/3’). Dyspneic patients correspond to those who arrested
effort due to the occurrence of significant dyspnea during the first three
levels. Echo Doppler of stress performed on table echocardiography of
effort (30W/3’). SPAP was measured at rest and at the end of each level
to the peak of the effort.
Results: Average age 42.3±1.3 years, 81.3% of female sex. Test effort:
182 patients were dyspnea(60.6%). hemodynamic data analysis of diagnostic qual-
ities of SPAP with the threshold Recommendations Americans showed the fol-
lowing results at peak effort: sensitivity(s)=0.96, specificity(sp)=0.34, positive
likelihood=1.45, Value positive predictive value (VPP)=69.0%, positive predictive
error (PPE)=31.0%, expected informative capacity (EIC)=26. Our results show
that maximum effort, the threshold giving the best ability to discriminate between
patients with and patients without dyspnea is 75.5 mmHg: (s)=0.80, (sp)=0.98,
positive likelihood=47.2, PPV=99%, PPE=1%, EIC=277
Conclusion: In Doppler cardiac stress,in predicting dyspnea justifying per-
cutaneous mitral dilation, the optimal value of the SPAPS at peak stress is
75.5 mmHg.
© Elsevier Masson SAS. All rights reserved.
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Thoracic involvement of systemic lupus erythematosus
Sonia Hammami (1), Olfa Berriche (2), Kaldoun Benhamda (3), Faouzi
Maatoug (3)
(1) Faculté de Médecine Monastir, Nutrition Humaine et désordres méta-
boliques, Monastir, Tunisie – (2) Hôpital Fattouma Bourguiba, Service de
médecine interne, Monastir, Tunisie – (3) Hôpital Fattouma Bourguiba,
Cardiologie, Monastir, Tunisie
Background: Thoracic manifestations in systemic lupus erythematosus
(SLE) are less known than the skin, joint and renal manifestations. Few
studies have been devoted to assess the characteristics of such manifestation 
The aim of our study was to evaluate the clinical and laboratory as well as
the changing profile of the thoracic manifestations (heart and lung) in SLE
through features a single-center study
Patients and Methods: We retrospectively studied the records of patients
treated for SLE. The diagnosis of SLE was selected according to ACR criteria.
Patients were divided into two groups according to the presence or absence of
chest events related to lupus. 
Results: Among a cohort of 92 patients, 47 (43 women and 4 men, mean
age 32 years) had thoracic manifestations with a frequency of 51%. Pulmo-
nary involvement: pleurisies (n=20), lupus pneumonia (n=2), fibrosis (n=2)
and two cases of pulmonary arterial hypertension. Cardiac involvement was
noted in respectively: pericarditis (n=30), endocarditis (n=6) and myocarditis
(n=1). Pulmonary embolism was noted in two patients. The association
pleuro-pericarditis was the most frequent opening of the disease (n=17). In
monovariate correlation, thoracic manifestations were associated with a statis-
tically significant in renal, neurological, anemia, the presence of antiphospho-
lipid antibodies, the SLEDAI score of activity and taking the corticosteroid.
Of the 8 deaths in our series, six patients had thoracic manifestations.
Conclusions: Thoracic manifestations in SLE are common and highly
polymorphic, the prevalence varies from 50 to 70%. They are dominated by
the pleuro-pericarditis. These complications seem to be a prognostic indicator
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Left atrium and left ventricular longitudinal function on atrial
fibrillation secondary to mitral valve disease: implication of metallo-
proteinase remodeling and inflammation 
Rachid Mechmeche (1), Amira Zaroui (1), Monia Asmi (2), Sonia Aloui (2),
Mouna Ben Mana (2), Mohamed Kouki (2), Mohamed Sami Mourali (1),
Neziha Kaabachi (2)
(1) CHU la Rabta, Exploration fonctionnelles et reanimation, Tunis, Tuni-
sie – (2) CHU la Rabta, Service de biochimie, Tunis, Tunisie
We investigated the profile and the relation of matrix metalloproteinase 3
(MMP-3), tissue inhibitors of matrix metalloproteinases (TIMP-1 and TIMP-2),
and inflammatory markers (high-sensitive C-reactive protein) on rheumatic
mitral valve stenosis (MVS) with atrial fibrillation (AF). We have enrolled
105 patients with AF (45±11.56 y.o ) secondary to MVS and 42 healthy con-
trol subjects (36±14 y.o.). An echocardiography study was performed to
evaluate the area, the anatomy and the calcification degree of the mitral
valve, the morphology and the function of the left atrium (LA) and the left
ventricular function (Ejection fraction and myocardial longitudinal deforma-
tion by 2D strain). Patients with AF were older (51±12 vs 41±11 y,
p=0.001), had a less LA ejection fraction(26.5±6 vs 33±6.7%, p=0.002) ,
and a markedly alteration of the left ventricular global longitudinal
strain(GLS) (-13±3 vs -16.4±4%, p=0.003 compared to – 23±2% on control
group). We observed a disequilibria on the matrix metalloproteinase 3
(MMP-3 at 6.1±4.9 vs 8.8 ±3.5 ng/ml, p=0.033) and his inhibitor TIMPS-1
(143.16±66 vs 126 ±77 ng/ml, p=0.02) resulting on a lower ratio promoting
the collagen accumulation and fibrosis . we releaved also an elevation of
marker of inflammation on AF group compared to sinus rhythm group ( hs-
CRP at 6.2 ±2.2 vs 3.1±2.2 mg/l, p=0.002). The MMP-3 plasmatic level and
MMP-3/TIMP-1 ratio were correlated to the degree of MV calcification
(r=0.778, p<0.001 and r=0.523, p=0.002 respectively. The LV longitudinal
deformation and the LA function were correlated to MMP-3 level and the
extra cellular matrix remodeling (ECM) expressed by the MMP-3/TIMP-1
ratio (r=-0.456, p=0.005 and r=0.453, p=0.02)
This study suggest an implication of the MMP-3/TIMP-1 system in ECM
remodeling of the left atrium remodeling and the LV longitudinal function on
RMS on addition to a probably role of inflammatory markers on physiological
mechanisms of atrial fibrillation evolution 
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Predictors of outcome of repeat percutaneous mitral valvuloplasty
Sana Fennira (1), Saoussen Antit (2), Sana Sioua (2), Fethia Ben
Moussa (2), Khedija Mzoughi (2), Ihsen Zairi (2), Kaies Mrabett (2),
Sofien Kammoun (2), Sondos Kraiem (2)
(1) Hôpital Habib Thameur, Cardiologie, Tunis, Tunisie – (2) Hôpital
Habib Thameur, Tunis, Tunisie
Background: Symptomatic mitral restenosis develop in 7% to 40% of
patients after percutaneous mitral valvuloplasty (PMV). Currently, most of
these patients are referred for mitral valve replacement. However, it is
unknown if these patients may benefit from repeat PMV (re-PMV). The pur-
pose of this study is to assess the immediate and long-term results of the re-
PMV and analyze the different clinical and laboratory findings to determine
predictors of outcome of re-PMV.
Methods: Retrospective study from a series of 40 procedures of re-PMV
with the Inoue balloon at 8±4 years after prior procedure, performed between
1996 and 2011. A clinical and ultrasound follow-up was achieved in
31 patients with a mean follow-up period of 43±26 months. 
Results: The mean age of patients was 43±11 years. 87,5% of the pop-
ulation being female. The immediate procedural success was achieved in
31 patients (77.5%). A severe mitral regurgitation (MR) was observed in
3 patients (7.5%). A cerebrovascular stroke occurred in 1 patient (2.5%).
No death or cardiac tamponade were noted. Class III or IV of NYHA, a
pre-procedural MR, pulmonary hypertension and a Padial score > 10 were
identified as predictors of failure. Only a left atrial area ≤25 cm² was
linked to high risk of severe MR. At long-term, most patients (84%) had
no functional impairment, the mean mitral valve area was 1,5±0,33 cm².
mitral restenosis was observed in 13 patients (42%) at 53±30 months
[9;128] after re-PMV. 9 patients had mitral valve replacement (32%),
4 patients underwent a re-PMV (13%), 2 patients presented thromboem-
bolic events (6%) and no death. Only the male had been identified as a
predictor of restenosis. 
Conclusion: Re-PMV is a therapeutic alternative to surgery that is
effective and promising interesting immediate and long term results.
Analysis of clinical and mainly echographic parameters is useful for pre-
dicting the success of the gesture, which will allow a better selection of
candidates for re-PMV.
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Prevalence and clinical impact of QRS duration in patients with low-
flow/low-gradient aortic stenosis 
Frédéric Sebag (1), Nicolas Lellouche (2), Jean-Luc Monin (2)
(1) CHU Rennes, Service de Cardiologie et Maladies Vasculaires, Rennes,
France – (2) CHU Henri Mondor, Département de Cardiologie, Créteil,
France
Background: The impact of QRS duration on patients with low flow/low
gradient aortic stenosis (LF/LGAS) outcome remains unknown.
Aims: We evaluated the influence of QRS width on patients with LF/
LGAS prognosis.
Methods: We selected 88 consecutive patients referred in our institu-
tion for management of LF/LGAS from September 1994 to March 2007.
Baseline demographic, clinical, echocardiographic and electrocardio-
graphic data were collected. This population was divided in two groups
according to baseline QRS duration (QRS≥130ms or not). Follow-up data,
including electrocardiographic evolution and overall mortality were pro-
spectively collected. 
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Results: Forty-nine patients (56%) had QRS duration ≥130ms. The mean
follow-up of was 3.1 (2.2-6.2) years. In our population, 67 patients underwent
surgical aortic valve replacement. Longer QRS duration was a strong indepen-
dent predictor of overall mortality [HR=1.016; CI, 1.028–4.24; p=0.008]. In
addition, among surgical patients, there was no significant change in QRS dura-
tion between baseline and latest follow-up (125.7±26.4 vs. 130.8±25.2 ms;
p=0.82). 
Conclusion: Significant intraventricular conduction disturbances are
common in patients with LG/LFAS. Moreover QRS duration is strongly asso-
ciated with death in this selected population.
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Transthoracic, transesophageal echocardiography and 24-hour Holter
ECG for the detection of cardiac sources of embolism in patients with
stroke
A retrospective sudy of 220 patients
Ulric Vinsonneau (1), Gwenole Rohel (1), Marie Piquemal (1), Gregoire
Le Gall (2), Jean Francois Buchet (1), Amelie Le Blanc (3), Christian
Blanchard (3), Fabien Zagnoli (3), Philippe Paule (1)
(1) Hôpital d'instruction des armées, Cardiologie, Brest, France –
(2) CHU 'la cavale blanche', CIC, Brest, France – (3) Hôpital d'instruc-
tion des armées, Neurologie, Brest, France
Introduction: Embolism of cardiac origin accounts for around 15-40% of
ischemic strokes. ECG and transthoracic echocardiography (TTE) are com-
monly obtained during the evaluation of patient of ischemic stroke but specific
indications for the transesophageal (TEE) echocardiography and 24-hour
Holter ECG remain uncertain. 
Objectives: The aim of this study is the report the contribution of TTE,
TEE and 24-hour Holter ECG performed as a routine during the evaluation of
patients with ischemic stroke (IS) or transient ischemic attack (TIA).
Methods: This is a retrospective single-center study of 220 patients hospi-
talized between 01/01/2007 and 31/12/2010. for a first IS or TIA. 
Result:: One hundred forty three IS and 77 TIA are identified. The
average age of patients was 66 years (18-88 years). TTE/TEE/24-hour
Holter ECG allowed the diagnostis of cardiac sources of embolism in
135 patents (61.3%). TTE/TEE identified potential source of cardiogenic
embolism in 126 patients (52.2%). Twenty four-hour Holter ECG tracked
supraventricular arrhythmia in 15 patients (6.7%), 9 (4%) wich had non
contributory ultrasound assessment.
Conclusion: The systematic implementation of TTE/TEE/24-hour Holter
ECG is usefull for identifying potential sources of cardiogenic embolism.
The performance of TEE remain above the TTE. Twenty-four hour Holter
ECG should be recommended because it is a cost effective and non invasive
tool. 
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Echocardiographic factors determining immediate results of percuta-
neous mitral balloon commissurotomy 
Leila Bezdah, Hbib Ben Ahmed, Slim Sidhom, Wejdène Ouechtati, Hous-
sem Boussaid, Sami Marouène, Hédi Baccar
Hôpital Charles Nicolle, Cardiologie, Tunis, Tunisie
Objectives: Define echocardiographic predictors of the immediate results
of percutaneous mitral balloon commissurotomy (PMC)
Methods: PMC by the Inoue balloon was attempted in 247 patients
(mean age: 35 ans, 77% female) with severe mitral valve stenosis. All the
patients had undergone echocardiographic examination before PMC to
assess mitral anatomy, commissural calcification and to determine the
Wilkins score.
Results: the mean value of Wilkins score was 7,98±1,61(range 5-13)
and the mean mitral valve area (MVA) before PMC was 1±0,19cm² (range
0,5-1,4 cm²). Twenty-nine patients (11,7%) had one-commissural calcifica-
tion. After PMC, the mean MVA increased to 1,79±0,34cm² (p<0,001)
resulting in a success rate of 83%. Severe mitral regurgitation (MR) occured
in 5 patients (2%). Wilkins score was an independent predictor of the imme-
diate result of PMC, but if > 8, this score had a weak predictive value. Com-
missural morphology was another independent predictor of the immediate
result of PMC.
Conclusion: Echocardiography is now the cornerstone in the assessment of
mitral anatomy before PMC and should integrate Wilkins score and commis-
sural morphology for the optimal selection of patients to PMC.
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Q fever endocarditis in department of cardiology of Sfax: diagnosis,
treatment and outcome
Leila Abid (1), Amine Bahloul (2), Dorra Abid (2), R Hammami (1),
A Znazen (1), Samir Kammoun (1)
(1) CHU Hédi Chaker, Cardiologie, Sfax, Tunisie – (2) FMS, University
Hédi Chaker Hospital, Cardiology, Sfax, Tunisie
Unlike typical cases of endocarditis, the clinical presentation of chronic Q
fever is often nonspecific. In this study, we report our experience in managing
7 cases with Q fever endocarditis (QFE) notified in our hospital.
Patients included in this study were diagnosed with QFE from January
2005 to September 2011on the bases of C. burnetii phase I IgG titers higher
than 1: 800. Serology was performed in micro-imunofluorescence assay.
PCR detecting IS1111 spacer was performed on removed valves if patient
underwent surgery. All our patients were men with an average age of
46.5 years.  Three patients had a history of environmental exposure to C.
burnetii. The median time of symptomatology before diagnosis was
110.4 days (23-270). Six patients had valvular lesions, and one patient had
Dacron prosthesis. Serology performed for all patients showed that
5 patients had a phase I Ig G antibody titers higher than 1:6400 and two
patients with phase I Ig G antibody titers at 1: 800 and 1: 1600. Cardiac sur-
gery was performed in 3 patients and PCR was positive for the three
removed cardiac valve. Two patients died before confirmation of diagnosis.
They were operated urgently for hemodynamic indication and died because
of an early postoperative hemorrhage. Two patients received only doxycy-
cline. The first patient recovered and showed a decreased phase I IgG less
that 1:200 after 18 months of treatment and the second patient died because
of pulmonary embolism. For the remaining three cases, they received doxy-
cycline associated to hydroxychloroquine. Endocarditis due to C. Burnetii
has an unusual presentation and poses echocardiographic and laboratory
challenges in establishing a diagnosis. A rapid diagnosis allows for prompt
initiation of appropriate antimicrobial therapy and improved clinical out-
comes.
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Usefullness of hemoclot direct thrombin inhibitor assay in frail
patient treated by dabigatran etexilate
Emmanuelle Berthelot-Garcias (1), Cécile Lavenu-Bombled (2), Céline
Vertuyft (2), Lupe Orostegui-Giron (2), Céline Desconclois (2), Patrick
Assayag (3)
(1) Hôpital Lariboisière, Cardiologie, Paris, France – (2) Hôpital Bicêtre,
Hémostase, Le Kremlin-Bicêtre, France – (3) Hôpital Bicêtre, Cardiolo-
gie, Le Kremlin-Bicêtre, France
Purpose: Thrombin inhibitor dabigatran is now available in France for
stroke prevention in patients with atrial fibrillation. Advantages of this agent are
numerous. However, there are no antidotes to reverse this anticoagulant effect
and no recommended follow up of plasma concentration in case of bleeding. A
commercial dabigatran calibrator, the Hemoclot direct thrombin inhibitor assay
provides accurate measures of dabigatran plasmatic anticoagulant activity and
may help management of bleeding event in selected population. 
Methods: In appropriate use of Dabigatran, 3 patients (>80 year old) were
admitted in our hospital with serious bleeding requiring blood products. All of
our patients had recent introduction of Dabigatran Etexilate <2 months. Dabi-
gatran was administered as recommended dose 110 mg twice a day. Dabiga-
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tran activity dosage was dosed with Hemoclot at the hospital ‘s admission for
bleeding (Table). 
Results: 2/3 of our patients were very old (>80 years). All of our patients
had HAS-BLED score > 4. 2/3 of the patients had impaired renal function
(clearance <60mL/min). All our 3 patients had the serious bleeding event
shortly after the introduction of Dabigatran < 2 months. In the 3 cases, there
was a documented plasma overdose in Dabigatran Etexilate, in parallel with
impairment of renal function concomittent of bleeding. 
Conclusion: Our sample of cases highlights that in some selected frail
population (elderly, high HAS BLED score, moderate impairment of renal
function) dosage of Hemoclot (Anti IIa activity) could be helpfull to under-
stand the bleeding event and a tight follow up of renal function is important,
especially before and during the following weeks after the beginning of the
treatment (table above).
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Percutaneous transcatheter obliteration of prosthetic mitral paraval-
vular leaks
François Bagate, Benoit Gerardin, Olivier Belliard, Remy Pillière, Adèle
Nana
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Introduction: Prosthetic paravalvular leaks (PVL) of biological or
mechanical heart valves implanted surgically are sometimes responsible of
heart failure or hemolysis requiring reoperations, which are often of high risk.
The percutaneous occlusion of these leaks is an alternative treatment. The aim
is to assess the feasibility and efficacy of percutaneous transcatheter oblitera-
tion of paravalvular leaks.  
Methods: 10 patients underwent transcatheter closure of prosthetic mitral
paravalvular leaks from 2009 to 2013 in one center. All patients had symp-
toms of hemolysis and/or severe cardiac failure with high surgical risk. Each
percutaneous transcatheter intervention was guided by three dimensions trans-
esophageal echocardiography (3D TOE) and performed with different kinds of
Amplatzer devices. 
Results: Patients had high operative risk (average logistic EuroSCORE
1=21,76%) mainly because of previous cardiac surgeries (3 times in
2 patients, 2 times in 6 patients and 1 time in 2 patients). Implantation of a
device was impossible in 2 patients without any complication. Implantation of
a device has been technically successful in eight patients (80%):  out of them,
5 (50%) were immediately dramatically improved and remained asymptomatic
in the follow up. In the 3 other patients, 1 had an migration of the prosthesis
into the left atrium without consequence, 1 had few months after on 2 occa-
sions enlarged the leak in spite of 2 new successful implantations of prosthesis
and finally died of heart failure, 1 patient had a severe complication with a
dramatic worsening of the hemolysis on a residual leak leading to death in
spite of the full occlusion of the residual leak with a second device. 
Conclusions: Transcatheter closure of PLV is technically feasible and
facilitated by the 3D TEO and the provision of new devices. Despite the dif-
ficulties, the results of this short series demonstrate that this technique is an
attractive alternative to surgery in these high risks patients.
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Factors predicting mitral restenosis after successful percutaneous
mitral commissurotomy
Leila Bezdah, Emna Allouche, Hbib Ben Ahmed, Slim Sidhom, Hassen
Sammoud, Wejdène Ouechtati, Sami Marouène, Hédi Baccar
Hôpital Charles Nicolle, Cardiologie, Tunis, Tunisie
Introduction:  Percutaneous mitral commissurotomy (PMC) is the alterna-
tive treatment of choice for mitral stenosis (MS). Its immediate and medium
term results are comparable to those of surgical commissurotomy, however in
the long term there is a risk of restenosis. The purpose of this study is to deter-
mine the factors predicting restenosis after PMC.
Methods: 322 patients (66% women), average age: 35 ±13 years (9-75 years)
having a tight MS and treated by PMC with Inoué balloon. The anatomic
aspect of the mitral apparatus before PMC has been studied according to
the criteria of the Wilkins score with a concomitant study of the state of
mitral commissures. The primary success of PMC is defined as follows:
mitral area (MA) post-PMC >1,5 cm2 and gain in MA >25% and mitral
regurgitation (MR) ≤ grade 2. Mitral restenosis is defined as a MA
<1,5 cm2 and/or loss >50% of initial gain in MA.
Results:  The rate of primary success of PMC was 86% and mean MA post
PMC was 1,82±0,33 cm² compared to MA pre-PMC of 1±0,18 cm²
(p <0.0001). Opening of two commissures has been observed in 74% of
patients. After an average period of 62±32 months, only 12% of patients had
a dyspnea stage III-IV of NYHA, MA was 1,64±0.3 cm² (p<0.001) and mitral
restenosis happened in 47 patients (20%) after a period of 60,48±27 months
(22–124 months).
The independent predictors of mitral restenosis after a successful PMC
were: previous surgical commisurotomy, Wilkins score > 8, MA after PMC
<1,8 cm² and absence of bicommissural opening post PMC.
Conclusion: A favorable anatomy of mitral apparatus and the optimisation
of immediate result of PMC are the guaranty for the maintain of good result
in the long term.
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Isolated aortic valve replacement in octogenarians before and after
the introduction of transcatheter aortic valve implantation
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(4) CHU Rennes, Rennes, France
Background: Aortic valve stenosis is the most frequently diagnosed val-
vular disease, with an incidence of 5% in octogenarians. The reference treat-
ment was surgical aortic valve replacement. But, since few years, a new
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Age Site of bleeding Clearance 
creatininemia
before event
(Cockroft, ml/min)  
Clearance 
at admission
Clearance at discharge Anti IIa activity 
(ng/ml) 
Anti IIa 
discharge 
87 Gastrointestinal 69 44 53 570 190
89 Hematuria 32 16 23 480 200
67 Gastro intestinal 42 29 25 400 110
